Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression

Venlafaxine‐associated pulmonary toxicity is rare, with only a few reports of pneumonitis, eosinophilic pneumonia, and asthma. We report a case of venlafaxine‐induced interstitial lung disease in a patient with coronavirus disease 2019 pandemic‐related depression. Chest imaging findings improved aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Okazaki, Akihito, Kita, Katsunao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163472/
https://www.ncbi.nlm.nih.gov/pubmed/35662783
http://dx.doi.org/10.1002/ccr3.5941
_version_ 1784719927920295936
author Okazaki, Akihito
Kita, Katsunao
author_facet Okazaki, Akihito
Kita, Katsunao
author_sort Okazaki, Akihito
collection PubMed
description Venlafaxine‐associated pulmonary toxicity is rare, with only a few reports of pneumonitis, eosinophilic pneumonia, and asthma. We report a case of venlafaxine‐induced interstitial lung disease in a patient with coronavirus disease 2019 pandemic‐related depression. Chest imaging findings improved after discontinuation of venlafaxine and treatment with corticosteroids.
format Online
Article
Text
id pubmed-9163472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91634722022-06-04 Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression Okazaki, Akihito Kita, Katsunao Clin Case Rep Case Reports Venlafaxine‐associated pulmonary toxicity is rare, with only a few reports of pneumonitis, eosinophilic pneumonia, and asthma. We report a case of venlafaxine‐induced interstitial lung disease in a patient with coronavirus disease 2019 pandemic‐related depression. Chest imaging findings improved after discontinuation of venlafaxine and treatment with corticosteroids. John Wiley and Sons Inc. 2022-06-02 /pmc/articles/PMC9163472/ /pubmed/35662783 http://dx.doi.org/10.1002/ccr3.5941 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Okazaki, Akihito
Kita, Katsunao
Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
title Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
title_full Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
title_fullStr Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
title_full_unstemmed Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
title_short Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
title_sort venlafaxine‐induced interstitial lung disease with covid‐19 pandemic‐related depression
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163472/
https://www.ncbi.nlm.nih.gov/pubmed/35662783
http://dx.doi.org/10.1002/ccr3.5941
work_keys_str_mv AT okazakiakihito venlafaxineinducedinterstitiallungdiseasewithcovid19pandemicrelateddepression
AT kitakatsunao venlafaxineinducedinterstitiallungdiseasewithcovid19pandemicrelateddepression

Ejemplares similares